Tevogen Bio’s strategic partners share our values and mission. We believe the perspective and expertise afforded by these collaborations to be fundamental in driving our rapid growth.
BioCentriq is New Jersey Innovation Institute’s pioneering cell and gene therapy process development and clinical manufacturing center. This partnership enhances development capacity of Tevogen Bio’s proprietary targeted T cell therapy for COVID-19 and brings us one step closer to our goal of developing affordable lifesaving therapies for viral infections, several solid tumors, and common hematologic malignancies.
© 2021 Tevogen Bio. All Rights Reserved.